Australia - English - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - pregabalin, quantity: 300 mg - capsule, hard - excipient ingredients: gelatin; iron oxide red; purified talc; purified water; pregelatinised maize starch; sodium lauryl sulfate; titanium dioxide; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - lyraccord (pregabalin) is indicated for the treatment of neuropathic pain in adults.,lyraccord (pregabalin) is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.

Australia - English - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - pregabalin, quantity: 75 mg - capsule, hard - excipient ingredients: gelatin; iron oxide red; sodium lauryl sulfate; pregelatinised maize starch; purified water; titanium dioxide; purified talc; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - lyraccord (pregabalin) is indicated for the treatment of neuropathic pain in adults.,lyraccord (pregabalin) is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.

Australia - English - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - pregabalin, quantity: 300 mg - capsule, hard - excipient ingredients: gelatin; sodium lauryl sulfate; purified talc; purified water; pregelatinised maize starch; iron oxide red; titanium dioxide; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - pregabalin intas (pregabalin) is indicated for the treatment of neuropathic pain in adults.,pregabalin intas (pregabalin) is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.

Australia - English - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - pregabalin, quantity: 300 mg - capsule, hard - excipient ingredients: gelatin; purified talc; sodium lauryl sulfate; purified water; pregelatinised maize starch; titanium dioxide; iron oxide red; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - lyraccord (pregabalin) is indicated for the treatment of neuropathic pain in adults.,lyraccord (pregabalin) is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.

Australia - English - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - pregabalin, quantity: 150 mg - capsule, hard - excipient ingredients: sodium lauryl sulfate; purified water; purified talc; titanium dioxide; gelatin; pregelatinised maize starch; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - lyraccord (pregabalin) is indicated for the treatment of neuropathic pain in adults.,lyraccord (pregabalin) is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.

Australia - English - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - glucose, quantity: 50 g/l; sodium chloride, quantity: 4.5 g/l - injection - excipient ingredients: water for injections; hydrochloric acid - sodium chloride and glucose intravenous infusion is indicated for replenishing fluid losses, as an energy source and for restoration or maintenance of sodium and chloride ion concentrations. it may be used as a vehicle of drug delivery where intravenous delivery is appropriate and the drug is compatible with this solution.

Australia - English - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - epirubicin hydrochloride, quantity: 200 mg - injection, concentrated - excipient ingredients: water for injections; sodium chloride; hydrochloric acid - epirubicin has produced responses in a wide spectrum of neoplastic diseases, and is indicated for the treatment of breast cancer, gastric cancer, ovarian cancer, small cell lung cancer, lymphoma (non-hodgkin's lymphoma), advanced/ metastatic soft tissue sarcoma, superficial bladder cancer (tis; ta). in bladder cancer, epirubicin is also indicated in the prophylaxis of recurrence after transurethral resection of stage t1 papillary cancers and stage ta multifocal papillary cancers (grades 2 and 3).

Australia - English - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - tacrolimus, quantity: 1 mg - capsule, hard - excipient ingredients: hypromellose; gelatin; ethanol absolute; lactose; titanium dioxide; purified water; magnesium stearate; methyl chloride; croscarmellose sodium; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - indicated for use as an adjunct to liver, kidney, lung or heart allograft transplantation in adults and children

Australia - English - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - tacrolimus -

Australia - English - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - tacrolimus -